No significant differences in TERT promoter mutations distribution were determined across racial and sex subgroups among patients with glioma, soft-tissue sarcoma, bladder, colorectal, NSCLC, and thyroid cancers (Fig. 3; Supplementary Table S7). Here, TERT is linked to thyroid gland carcinoma.